Cancer Struggles

Category : Lung Cancer | Sub Category : Lung Cancer Posted on 2026-03-31 03:55:23

Across the country, cancer patients and survivors are speaking out about the heavy toll the disease takes on individuals, families, and livelihoods — stressing not only the health but the social and economic burden of cancer in Nigerian communities. Survivors share experiences of interrupted education, debt, and loss while battling the disease, driving home the need for stronger support systems. (Vanguard News)

Multilingual Ovarian Cancer Awareness Project Launched

A Nigerian scholar has launched a new ovarian cancer awareness initiative that uses QR‑code technology and a central online landing page to expand access to culturally relevant, multilingual educational resources. The project aims to reach women across language barriers and increase knowledge about symptoms and early detection. (News Agency of Nigeria)

Free Colorectal Cancer Screening Reaches 1,000+ Nigerians

In support of early detection, the David Omenukor Foundation provided free colorectal cancer screening to more than 1,000 people, combining testing with health education and expert‑led workshops to reduce late‑stage diagnoses. The campaign was part of Colorectal Cancer Awareness Month activities. (The Guardian Nigeria)

Fake Cancer Drugs Flooding Nigeria — NAFDAC Warns

The National Agency for Food and Drug Administration and Control (NAFDAC) has issued an urgent warning about the proliferation of counterfeit cancer medications in Nigeria. These fake drugs — identified by irregular batch numbers and poor packaging — pose serious risks of treatment failure, complications, or even death. Health authorities are calling on patients and pharmacists to verify all oncology medication sources. (P.M. News)

Advocates Warn Late Detection & Stigma Still Driving Deaths

Cancer advocacy groups marched in Abuja, emphasising that late diagnosis, stigma, and limited access to care continue to worsen outcomes in Nigeria. Organisers of the awareness walk urged government and community action to prioritise early screening, better treatment access, and reduced stigma against cancer patients. (Premium Times Nigeria)

Filmmaker Highlights Low Breast Cancer Survival in Nigeria

A British‑Nigerian filmmaker has spotlighted a grim statistic — Nigeria’s five‑year breast cancer survival rate is about 32%, substantially lower than in high‑income countries. The documentary screening in Lagos brought policymakers, advocates and public health voices together to push for improved awareness, care access, and policy action. (Vanguard News)

First Immunotherapy Clinical Trial for Colorectal Cancer Begins

In a major medical milestone, Nigeria has launched its first immunotherapy clinical trial for colorectal cancer at Lagos University Teaching Hospital (LUTH). The study, conducted with international partners and research institutes, represents a significant step in advancing cancer treatment research and expanding therapeutic options for patients in Nigeria. (University Of Lagos)

Cancer Leadership Recognition: Zainab Shinkafi‑Bagudu

Zainab Shinkafi‑Bagudu, President‑Elect of the Union for International Cancer Control (UICC) and CEO of the Medicaid Cancer Foundation, was recently recognised among “100 Award‑Winning Amazons” by a major Nigerian publication for her global cancer advocacy work and leadership in driving policy, awareness, and support initiatives. (Oncodaily)

These developments illustrate a multi‑front cancer landscape in Nigeria:

• Patient voices and real challenges — highlighting the human cost of delayed diagnosis and inadequate support.

• Public health education and outreach innovations — improving access to cancer information across languages and regions.

• Screening and prevention efforts — early detection campaigns are expanding beyond headline cancers to include colorectal disease.

• Threats to treatment integrity — fake cancer drugs undermine care and require strict regulation and public vigilance.

• Research and treatment advancements — clinical trials and immunotherapy research mark progress in cancer therapy options.

• Leadership and advocacy recognition — strong voices at home and abroad are pushing for systemic improvements.